BridgeMD
New treatment option for HIV Prevention
Official title WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
ClinicalTrials.gov ID: NCT06656676
What this study is testing
- What it's testing
- HIV prevalence among transgender women (TW) in the United States is high (\~14%). The best way to reduce HIV incidence in this population is to link TW to HIV pre-exposure prophylaxis (PrEP), which can reduce HIV transmission by up to 86%, with optimal adherence.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, men only
You may be able to join if
- Eligible participants in the transgender women group (N=69) must:
- Self-identify as a transgender woman (e.g., was assigned male at birth, but currently reports a feminine gender identity)
- Be between the ages of 18 and 65
- Currently live in the Denver area
- Speak English or Spanish
You likely can't join if
- Participants in the transgender women group are excluded if they:
- Currently live with HIV
- Do not meet one or more of the inclusion criteria above Participants in the PrEP service providers group are excluded if they:
- Do not live in the Denver area
- Do not meet one or more of the inclusion criteria above
See the full eligibility criteria
- Eligible participants in the transgender women group (N=69) must:
- Self-identify as a transgender woman (e.g., was assigned male at birth, but currently reports a feminine gender identity)
- Be between the ages of 18 and 65
- Currently live in the Denver area
- Speak English or Spanish
- Be HIV-negative (via Alere Determine)
- Not have participated in the development of WePrEP
- Not currently take PrEP, but report they are "interested in doing more to protect themselves from HIV" \ \ We note that 1/3 of our RCT participants in the transgender women's group will be Black and/or Hispanic/Latina...
- Not have participated in the development of WePrEP
- Live in the Denver area and (as a part of their employment responsibilities) discuss PrEP use with potential end-users.
- Have helped at least 1 TW make a decision about PrEP (e.g., whether or not to use it, which specific PrEP modality, etc...) in the last month.
- Participants in the transgender women group are excluded if they:
- Currently live with HIV
- Do not meet one or more of the inclusion criteria above Participants in the PrEP service providers group are excluded if they:
- Do not live in the Denver area
- Do not meet one or more of the inclusion criteria above
The study team makes the final eligibility decision.
Where it's taking place
- Sheridan, Colorado, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sheridan, Colorado, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.